These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9752292)
1. [Acute promyelocytic leukemia, histone deacetylase, and response to retinoids]. Jeanteur P Bull Cancer; 1998 Apr; 85(4):301-3. PubMed ID: 9752292 [TBL] [Abstract][Full Text] [Related]
2. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654 [TBL] [Abstract][Full Text] [Related]
3. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications. He LZ; Merghoub T; Pandolfi PP Oncogene; 1999 Sep; 18(38):5278-92. PubMed ID: 10498880 [TBL] [Abstract][Full Text] [Related]
4. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial]. Chen SJ; Chen LJ; Zhou GB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426 [TBL] [Abstract][Full Text] [Related]
5. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha. Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608 [TBL] [Abstract][Full Text] [Related]
6. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655 [TBL] [Abstract][Full Text] [Related]
7. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia. Tussié-Luna MI; Rozo L; Roy AL Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Minucci S; Nervi C; Lo Coco F; Pelicci PG Oncogene; 2001 May; 20(24):3110-5. PubMed ID: 11420727 [TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy. Randolph TR Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449 [TBL] [Abstract][Full Text] [Related]
10. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230 [TBL] [Abstract][Full Text] [Related]
11. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo. Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037 [TBL] [Abstract][Full Text] [Related]
12. Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia patients treated with arsenic trioxide (As2O3). Zhang T; Westervelt P; Hess JL Mod Pathol; 2000 Sep; 13(9):954-61. PubMed ID: 11007035 [TBL] [Abstract][Full Text] [Related]
13. Autophagic degradation of an oncoprotein. Bøe SO; Simonsen A Autophagy; 2010 Oct; 6(7):964-5. PubMed ID: 20724820 [TBL] [Abstract][Full Text] [Related]
14. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166 [TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein. Jansen JH; Löwenberg B Semin Hematol; 2001 Jan; 38(1):37-41. PubMed ID: 11172538 [TBL] [Abstract][Full Text] [Related]
16. Targeting the PML/RAR alpha translocation product triggers apoptosis in promyelocytic leukemia cells. Nason-Burchenal K; Takle G; Pace U; Flynn S; Allopenna J; Martin P; George ST; Goldberg AR; Dmitrovsky E Oncogene; 1998 Oct; 17(14):1759-68. PubMed ID: 9778041 [TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response. Vitoux D; Nasr R; de The H Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032 [TBL] [Abstract][Full Text] [Related]
18. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells. Chen Z; Wang W; Pan J; Chen L; Xue Y Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538 [TBL] [Abstract][Full Text] [Related]
19. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement. Gau JP; Young JH; Lin TH; Yang YS Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]